Search Results 51-60 of 3472 for Nityr
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
D., conducts research in structural biology, computational biology, metabolomics and proteomics. Focus areas. Dynamic metabolomic profiling and determination of ...
The Patient Group 1 primary objective is to measure the distribution of 90Y glass microspheres throughout the tumor and non-tumor hepatic parenchyma, as ...
About Student Research. Justin Peters (2008–2012). Getting back to basics with DNA. Each human cell is crammed with 2 meters of DNA, meaning that there is ...
The AURORA study will be conducted to confirm the efficacy and safety of cenicriviroc (CVC) for the treatment of liver fibrosis in adult subjects with NASH.
This multi-center, prospective, observational cohort study will evaluate the effectiveness, safety and utilization of treatments in patients with advanced basal ...
Navitoclax and sorafenib tosylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Participation eligibility.
Dr. LaRusso holds several U.S. patents for his work in the Cholangiopathies Lab and collaborates with other investigators on liver diseases.
Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift now and help create new and better solutions for more than 1.3 million patients who turn to Mayo Clinic each year.